TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Surgical Science Sweden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
76,967
|
79,565
|
72,117 |
| Financial expenses |
1,002
|
59
|
1,751 |
| Earnings before taxes |
13,763
|
24,177
|
18,707 |
| EBITDA |
17,833
|
22,059
|
16,372 |
| Total assets |
477,053
|
423,817
|
417,814 |
| Current assets |
124,146
|
89,329
|
74,259 |
| Current liabilities |
44,637
|
21,173
|
27,489 |
| Equity capital |
420,375
|
391,602
|
380,692 |
| - share capital |
222
|
230
|
228 |
| Employees (average) |
256
|
249
|
227 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
88.1%
|
92.4%
|
91.1% |
| Turnover per employee |
301
|
320
|
318 |
| Profit as a percentage of turnover |
17.9%
|
30.4%
|
25.9% |
| Return on assets (ROA) |
3.1%
|
5.7%
|
4.9% |
| Current ratio |
278.1%
|
421.9%
|
270.1% |
| Return on equity (ROE) |
3.3%
|
6.2%
|
4.9% |
| Change turnover |
107
|
7,238
|
39,158 |
| Change turnover % |
0%
|
10%
|
119% |
| Chg. No. of employees |
7
|
22
|
106 |
| Chg. No. of employees % |
3%
|
10%
|
88% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.